Oxytocin inhibitors

Details Oxytocin inhibitors Oxytocin inhibitors

2005-07-05

2005-07-05

Kumar, Shailendra (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Amino nitrogen containing

C564S153000, C549S366000, C548S248000, C548S374100, C546S169000, C546S304000, C546S310000, C544S297000, C544S299000, C544S300000, C544S303000, C544S355000, C544S406000, C514S249000, C514S255030, C514S269000, C514S275000, C514S311000, C514S350000, C514S378000, C514S406000, C514S456000, C514S616000

Reexamination Certificate

active

06914160

ABSTRACT:
This invention relates to compounds of formula (I)

REFERENCES:
patent: 2503059 (1950-04-01), Miescher et al.
patent: 2599000 (1952-06-01), Kerwin et al.
patent: 3381009 (1968-04-01), Palazzo
patent: 3511836 (1970-05-01), Hess
patent: 3527761 (1970-09-01), Archibald et al.
patent: 3997666 (1976-12-01), Witte et al.
patent: 4026894 (1977-05-01), Winn et al.
patent: 4188390 (1980-02-01), Campbell
patent: 4252721 (1981-02-01), Silvestrini et al.
patent: 4315007 (1982-02-01), Manoury
patent: 4703063 (1987-10-01), Imai et al.
patent: 5576322 (1996-11-01), Takase et al.
patent: 5698560 (1997-12-01), Onoda et al.
patent: 5945117 (1999-08-01), El-Rashidy et al.
patent: 0463756 (1992-01-01), None
patent: 0526004 (1993-02-01), None
patent: 0995750 (2000-04-01), None
patent: 0995751 (2000-04-01), None
patent: 1092718 (2001-04-01), None
patent: 1092719 (2001-04-01), None
patent: 1097719 (2001-05-01), None
patent: WO 9111172 (1991-08-01), None
patent: WO 9306104 (1993-04-01), None
patent: WO 9307149 (1993-04-01), None
patent: WO 9312095 (1993-06-01), None
patent: WO 9400453 (1994-01-01), None
patent: WO 9402518 (1994-02-01), None
patent: WO 9405661 (1994-03-01), None
patent: WO 9519978 (1995-07-01), None
patent: WO 9830560 (1998-07-01), None
patent: WO 9849166 (1998-11-01), None
patent: WO 9855148 (1998-12-01), None
patent: WO 9902159 (1999-01-01), None
patent: WO 9924433 (1999-05-01), None
patent: WO 9930697 (1999-06-01), None
patent: WO 9954333 (1999-10-01), None
patent: WO 0002550 (2000-01-01), None
patent: WO 0024745 (2000-05-01), None
patent: WO 0028993 (2000-05-01), None
patent: WO 0127112 (2001-04-01), None
patent: WO 0127113 (2001-04-01), None
Pierre et al, J. Org. Chem, vol. 59, 1994, p. 1072-1077.
Keating, et al., “Molecular Diversity via a Convertible Isocyanide in the Ugi Four-Component Condensation”,J. Am. Chem. Soc117, pp. 7842-7843 (1995).
Keating, et al., “Postcondensation Modifications of Ugi Four-Component Condensation Products: 1-isocyancyoclohexene as a Convertible Isocyanide. Mechanism of Conversion, Synthesis of Diverse Structures, and Demonstration of Resin Capture”,J. Am. Chem. Soc.118, pp. 2574-2583 (1996).
Ley, et al., “A Ploymer-Supported [1,3,2]Oxazaphopholidine for the Conversion of Isothiocyanates to Isocyanides and Their Subsequent Use in an Ugi Reaction”,Bioorganic&Medicinal Chemistry Letters12, pp. 1813-1816 (2002).
Weber, et al., “An Improved Procedure for the Hofmann Carbylamine Sunthesis of Isonitriles”,Tetrahedron Letters17, pp. 1637-1640 (1972).
Melman, et al., “The Epidemiology and Pathophysiology of Erectile Dysfunction”,The Journal of Urology161, pp. 5-11 (1999).
Rotella, et al., “N-3-Substituted Imidazoquinazolinones: Potent and Selective PDE5 Inhibitors as Potential Agents for Treatment of Erectile Dysfunction”,J. Med. Chem.43, pp. 1257-1263 (2000).
Mukalyama, et al., “The Deoxygenation of Isocyanates by 2-Phenyl-3-methyl-1,3,2-oxazaphospholidine. A Convenient Method for the Preparation of Isonitrilles”,Bulletin of the Chemical Society of Japan38(5), pp. 858-859 (1965).
Berge, et al., “Pharmaceutical Salts”,Journal of Pharmaceutical Sciences66(1), pp. 1-19 (1977).
Ugl, et al., “New Methods in Preparative Organic Chemistry IV”,Angew. Chemie Int. Edition4(6), pp. 472-484 (1965).
Creedon, et al., “Dehydration of Formamides Using the burgess Reagent: A New Route to Isocyandes”,J. Chem. Soc., Perkin Trans. 1, pp. 1015-1017 (1998).

Affiliated with

Also associated with

Rating

Oxytocin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxytocin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxytocin inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3386858